Video | 15 February 2020 A recipe for an affordable medicine goes bad 1 min RESEARCH AND DEVELOPMENT Governments use taxpayer money to try to get Big Pharma to develop medicines we need. These incentives are supposed to be the ingredients for an affordable medicine. Watch the video to see how it really turns out. Share this message! Tell your leaders: We won’t pay twice for medicines any more. Share on Read, watch, share Filter by - Any -BlogEventsFeature storyInfographicLetterNewsletterOpinion articlePress releaseReportResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Technical brief Technical brief | 24 June 2026 Diagnostics Research and development The diagnostic blind spot in the 2026 Bundibugyo Ebola disease outbreak: access gaps and priority actions Statement Statement | 16 June 2026 Research and development European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access Press release Press release | 16 June 2026 Research and development Europe Public investment demands public benefits: European Biotech Act must deliver for people 2 min 08 June 2026 Research and development Principles for equitable access to medical tools for Ebola disease caused by Bundibugyo virus Letter | 17 April 2026 Pandemic preparedness Research and development Open letter: Linking pathogens and data access to enforceable benefit-sharing commitments in the Pandemic Agreement Report Report | 09 April 2026 Research and development KenyaRwandaSouth Africa Shifting Global Health R&D Funding: Opportunities in a Changing Landscape Photo credit: MSF/Martim Gray Pereira Press release Press release | 19 March 2026 Pandemic preparedness Research and development European Union MSF calls on EU to unlock progress in final Pandemic Agreement talks 2 min Letter Letter | 16 March 2026 Research and development European Union Open letter: The Critical Medicines Act must deliver equitable, affordable access to medicines for all Load More
Technical brief Technical brief | 24 June 2026 Diagnostics Research and development The diagnostic blind spot in the 2026 Bundibugyo Ebola disease outbreak: access gaps and priority actions
Statement Statement | 16 June 2026 Research and development European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access
Press release Press release | 16 June 2026 Research and development Europe Public investment demands public benefits: European Biotech Act must deliver for people 2 min
08 June 2026 Research and development Principles for equitable access to medical tools for Ebola disease caused by Bundibugyo virus
Letter | 17 April 2026 Pandemic preparedness Research and development Open letter: Linking pathogens and data access to enforceable benefit-sharing commitments in the Pandemic Agreement
Report Report | 09 April 2026 Research and development KenyaRwandaSouth Africa Shifting Global Health R&D Funding: Opportunities in a Changing Landscape
Photo credit: MSF/Martim Gray Pereira Press release Press release | 19 March 2026 Pandemic preparedness Research and development European Union MSF calls on EU to unlock progress in final Pandemic Agreement talks 2 min
Letter Letter | 16 March 2026 Research and development European Union Open letter: The Critical Medicines Act must deliver equitable, affordable access to medicines for all
